Intrauterine Devices Market Forecast Report | Global Outlook 2030

[Research Report] The global intrauterine devices market is expected to reach US$ 7.2 Bn in 2031 from US$ 4.1 Bn in 2022. The market is estimated to grow with a CAGR of 6.0% during the period 2022-2031.

Market Insights and Analyst View:

Intrauterine devices (IUDs) are highly effective and reversible forms of long-term contraception used by millions of individuals worldwide. The small, T-shaped devices are inserted into the uterus by a healthcare provider, where they protect against pregnancy for several years. Intrauterine devices (IUDs) are of two types:

1. Hormonal IUDs: These IUDs release a progestin hormone into the uterus, which thickens cervical mucus, making it difficult for sperm to reach the egg. Hormonal IUDs are highly effective and can last upto 3 to 7 years, depending on the brand.
2. Non-Hormonal (Copper) IUDs: Copper IUDs release copper ions, which are toxic to sperm, thus preventing fertilization. They can provide contraception for up to 10 years.

IUDs are among the most effective forms of contraception, with a failure rate of less than 1%. IUDs require minimal maintenance and can provide protection for several years, reducing the risk of user error. IUDs are reversible; fertility returns once the devices are removed, making them suitable for individuals who plan to have children.

The growing awareness about IUDs and their benefits among healthcare providers and the general population and increasing government initiatives and public health programs in various countries to promote the use of IUDs as a cost-effective and reliable method of contraception are the key factors propelling the growth of global intrauterine devices market size. However, the risk of infection associated with IUD insertion may hamper the market's growth. Additionally, IUDs can become partially or fully dislocated within the uterus, reducing effectiveness. This factor may restrain the growth of the market during the forecast period.

Growth Drivers and Challenges:

Benefits offered by IUDS

Intrauterine devices (IUDs) are renowned for their exceptional efficiency as a contraceptive method, making them one of the most reliable choices available. IUDs are small, T-shaped devices inserted into the uterus by a healthcare provider. They offer a range of advantages that contribute to their high efficacy in preventing pregnancy. The effectiveness of IUDs is remarkable. They have a failure rate of less than 1%, making them one of the most reliable forms of contraception available. Traditionally, IUDs are considered the gold standard for preventing pregnancy. IUDs are renowned for their longevity. Once inserted, they can provide contraception for an extended period, ranging from 3 to 10 years, depending on its type and brand. IUDs reduce the risk of user errors often associated with other contraceptive methods, such as oral contraceptives or condoms. IUDs require minimal maintenance. After insertion, users can go about their daily lives without thinking about contraception. This low-maintenance aspect enhances their reliability. IUDs provide privacy and discretion. Hormonal IUDs lead to lighter periods and reduced menstrual pain. This added benefit can significantly improve the quality of life for those who experience heavy menstrual bleeding or conditions like endometriosis.

In conclusion, the high efficiency of IUDs as a contraceptive method arises from their dual mechanisms of action, their exceptionally low failure rate, long-term contraception, reversibility, low maintenance, privacy, and potential to reduce menstrual symptoms.

Strategic Insights

Report Segmentation and Scope:

The “Global Intrauterine Devices Market” is segmented based on type, age group, end users, and geography. The intrauterine devices market by type is categorized into copper IUD and hormonal IUD. Based on age group, the market is segmented into 15-24 years, 25-34 years, 35-40 years, and above 40 years. The end-user segment is divided into hospitals, specialty clinics, and others.

The intrauterine devices market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

Based on the end-user, the global intrauterine devices market was segmented into hospitals, specialty clinics, and others. In 2022, the hospitals segment held the largest market share by end users. In addition, the specialty clinics segment is expected to grow fastest during the coming years. Hospitals often have well-established obstetrics and gynecology departments, making them key healthcare institutions for family planning services, including IUD insertion and management. Hospitals typically employ a wide range of healthcare professionals, including gynecologists and obstetricians, trained in family planning and contraceptive methods, including IUD insertion. This expertise makes hospitals a natural choice for IUD services. Hospitals also offer comprehensive healthcare services, and women often visit hospitals for prenatal care, childbirth, and postpartum care. Healthcare providers can discuss contraception options, including IUDs, during patient visits.

Hospitals have traditionally been significant players in the IUD market; however, the landscape of healthcare services is continually evolving. In recent years, there has been a trend toward expanding access to contraception services beyond traditional healthcare settings, including family planning clinics, community health centers, and private medical practices. Telemedicine and online platforms have also emerged as potential avenues for accessing contraceptive counseling and prescriptions.

Regional Analysis: 

Based on geography, the intrauterine devices market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In terms of revenue, North America dominated the intrauterine devices market share. The North American intrauterine devices market has been segmented into US, Canada, and Mexico. The intrauterine devices (IUDs) market in North America is dynamic and evolving segment of the broader healthcare industry. The market for IUDs in North America included the United States, Canada, and Mexico, with the United States being the region's largest and most influential market.

The IUDs market in North America had been experiencing steady growth. Factors contributing to this growth included increased awareness of long-acting reversible contraception (LARC) methods like IUDs, changing attitudes toward family planning, and efforts to improve access to contraception. Both hormonal and non-hormonal (copper) IUDs were available in North America. Several brands and models of IUDs were approved for use in the region, offering women a choice of contraception methods tailored to their needs and preferences. The accessibility of IUDs varied by country and region within North America. In the United States, for example, women could obtain IUDs through a range of healthcare providers, including gynecologists, family planning clinics, and primary care physicians. Canada and Mexico also had established healthcare systems that provided access to IUDs.

Insurance coverage for IUDs was a significant factor in their accessibility. In the United States, many insurance plans cover the cost of IUDs, making them more affordable for women. The Affordable Care Act (ACA) mandated insurance coverage for contraceptives, including IUDs, in the United States.

Public health initiatives in North America aimed to reduce unintended pregnancies by increasing access to contraception. These initiatives often included educational campaigns and support for healthcare providers.

The IUDs market is also witnessing research and development efforts to improve the design and features of these devices. This included innovations in IUD insertion techniques and the development of new hormonal IUD formulations.

Furthermore, Asia-Pacific region is expected to witness the fastest growth during the forecast period. The Asia-Pacific region's intrauterine devices (IUDs) market was characterized by a diverse landscape influenced by various cultural, economic, and healthcare considerations. The Asia-Pacific region is vast and comprises many countries with varying levels of development and healthcare infrastructure. The IUD market in the Asia-Pacific region is significant and has been experiencing growth. Factors contributing to this growth included population size, increased awareness of family planning methods, and efforts to expand access to contraception. Several governments in the Asia-Pacific region have implemented family planning programs aimed at reducing unintended pregnancies and promoting contraception use. These initiatives often included the distribution of contraceptives, including IUDs, to underserved populations. Some countries offer subsidized or free contraceptives to women in the Asia Pacific. NGOs and international organizations played a significant role in supporting family planning initiatives, including providing contraceptives like IUDs, in underserved areas. In some countries, IUDs were locally manufactured, contributing to their affordability and accessibility. Pregna is an Indian manufacturer of intrauterine devices, delivering high-quality IUDs to women who wish to remain safe from unwanted or unplanned pregnancy. 

Moreover, Europe held the second-largest market share in the global intrauterine devices market. As per the data from the United Nations published in 2021, around 8.1% of European women of reproductive age (i.e., 15- 49 years) use an intrauterine device (IUD) for contraception, and thus, IUDs are ranked as the third most commonly used contraceptive method in Europe.

Industry Developments and Future Opportunities:

Some of the activities undertaken by the company that have promoted its growth are product launches, expansion, and others. Such activities by the major market players will likely boost the global intrauterine devices market. Various initiatives taken by key players operating in the global intrauterine devices market are listed below:

1. In May 2023, Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, announced positive results of a Phase three study demonstrating that investigational device Copper 175 mm2 IUD — a next-generation, hormone-free, low-dose copper intrauterine device. The device met the primary efficacy outcome measurement of pregnancy prevention through 3 years of use. This newly designed, flexible frame allows the Copper 175 mm2 IUD to prevent pregnancies using less than half the amount of copper that is used in the other copper IUDs available in the market
2. In May 2021, Bayer completed its Mirena Extension Trial (MET). The study assessed whether Mirena is safe and effective as a birth control method beyond 5 years of use. Further, the menstrual blood loss (in women who had Mirena inserted to indicate heavy menstrual bleeding) and safety were assessed. The study concluded that the 52-mg levonorgestrel-releasing intrauterine system, initially approved for five years, maintains high contraceptive efficacy, user satisfaction, and a favorable safety profile through 8 years of use.
3. In March 2022, CooperSurgical Inc. initiated a study  to evaluate the safety of a new inserter design for Paragard (intrauterine copper contraceptive). The study will be conducted in female subjects of child bearing age.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global intrauterine devices market include Actavis, Bayer, Teva Pharmaceuticals, Allergan, ANI Pharmaceuticals, Eurogine, OCON Medical, Pregna, SMB Corporation, HLL Lifecare, HRA Pharma, and Besins HealthCare among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve a large set of customers and subsequently increase their market share.

REGIONAL FRAMEWORK

Intrauterine Devices Market Report Analysis

MARKET PLAYERS

Intrauterine Devices Market Report Scope